NCT02633137 2024-08-30Sequential Chemotherapy and Lenalidomide Followed by Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell LymphomaMemorial Sloan Kettering Cancer CenterPhase 2 Completed49 enrolled 8 charts